Addus HomeCare Corporation (ADUS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Addus HomeCare Corporation (ADUS) trades at $106.31 with AI Score 92/100 (Grade A+). Addus HomeCare Corporation provides personal care, hospice, and home health services to individuals in the United States. Market cap: $1.98B, Sector: Healthcare.
Price live · AI analysis from May 10, 2026ADUS stock analysis for 2026: Analysts have set a consensus price target of $125.50 for Addus HomeCare Corporation, suggesting 18.1% upside from the current price of $106.31. The AI MoonshotScore is 92/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
ADUS: 1/1 perspectives are bullish.
How is this calculated? →Addus HomeCare Corporation (ADUS) Healthcare & Pipeline Overview
Addus HomeCare Corporation delivers personal care, hospice, and home health services, primarily catering to elderly and disabled individuals across the United States. Operating in a fragmented market, Addus distinguishes itself through a diversified service portfolio and a presence in multiple states, addressing the growing demand for in-home care solutions.
What Is the Investment Thesis for ADUS?
Addus HomeCare Corporation presents a compelling investment case driven by the increasing demand for in-home care services due to the aging population and the growing preference for receiving care in a home setting. With a market capitalization of $1.98B and a P/E ratio of 12.3, Addus demonstrates financial stability and growth potential. The company's diversified service offerings across personal care, hospice, and home health segments provide resilience against market fluctuations. A gross margin of 32.5% and a profit margin of 6.9% indicate efficient operations. Key growth catalysts include strategic acquisitions and expansion into new geographic markets. However, potential risks include regulatory changes and labor shortages in the healthcare industry. The company's free cash flow of $0.07 billion provides financial flexibility for future investments and acquisitions.
Based on FMP financials and quantitative analysis
ADUS Key Highlights
- Market Cap of $1.98B reflects substantial investor confidence in Addus's market position.
- P/E Ratio of 12.3 suggests that the company is reasonably valued compared to its earnings.
- Gross Margin of 32.5% indicates efficient cost management in service delivery.
- Profit Margin of 6.9% demonstrates the company's ability to generate profits from its revenue streams.
- Operations across 206 offices in 22 states provide a diversified geographic footprint, reducing reliance on any single market.
Who Are ADUS's Competitors?
ADUS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| LHCG LHC Group, Inc. | $169.81 | +0.00% | $5.29B | 45 |
| AMCR Amcor plc | $44.46 | -1.20% | $20.56B | 44 |
| CHE Chemed Corporation | $480.04 | -1.96% | $6.37B | 87 |
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| TOI The Oncology Institute, Inc. | $5.45 | +3.22% | $544.91M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ADUS's Key Strengths?
- Diversified service offerings across personal care, hospice, and home health.
- Established presence in multiple states.
- Strong relationships with payor clients.
- Experienced management team.
What Are ADUS's Weaknesses?
- Exposure to regulatory changes and reimbursement pressures.
- Labor shortages in the healthcare industry.
- Dependence on government funding.
- Competition from other national and regional providers.
What Could Drive ADUS Stock Higher?
- Demographic trends indicate an aging population, driving increased demand for home healthcare services.
- Potential acquisitions of smaller home healthcare providers to expand market share by Q4 2026.
- Increasing adoption of value-based care models, incentivizing home-based care solutions.
- Technological advancements in remote patient monitoring and telehealth, enhancing service delivery.
What Are the Key Risks for ADUS?
- Insider selling — insiders were net sellers of roughly $1.9M recently.
- Changes in government regulations and reimbursement policies could negatively impact revenue.
- Labor shortages in the healthcare industry may increase operating costs and limit service capacity.
- Economic downturn could reduce consumer spending on discretionary healthcare services.
- Competition from other national and regional home healthcare providers may erode market share.
What Are the Growth Opportunities for ADUS?
- Expansion into New Geographic Markets: Addus has the opportunity to expand its presence into new states and regions, leveraging its established infrastructure and expertise. The company can target areas with a high concentration of elderly population and limited access to home healthcare services. This expansion can be achieved through strategic acquisitions or organic growth, increasing the company's market share and revenue streams. The market size for untapped geographic regions is estimated to be $50 billion by 2030.
- Strategic Acquisitions: Addus can pursue strategic acquisitions of smaller home healthcare providers to expand its service offerings and geographic reach. Acquisitions can provide access to new markets, technologies, and talent, accelerating the company's growth trajectory. The company can focus on acquiring companies with complementary service lines or a strong presence in attractive geographic areas. The market for home healthcare acquisitions is estimated to be $20 billion annually.
- Increased Focus on Technology: Addus can invest in technology solutions to improve operational efficiency, enhance patient care, and reduce costs. This includes implementing electronic health records (EHRs), telehealth platforms, and remote monitoring devices. Technology can enable the company to provide more personalized and proactive care, improving patient outcomes and satisfaction. The market for healthcare technology is projected to reach $400 billion by 2027.
- Development of Specialized Care Programs: Addus can develop specialized care programs for specific patient populations, such as individuals with Alzheimer's disease, Parkinson's disease, or other chronic conditions. These programs can provide tailored care solutions that address the unique needs of these patients, improving their quality of life and reducing healthcare costs. The market for specialized care programs is estimated to be $30 billion by 2025.
- Partnerships with Healthcare Providers: Addus can form partnerships with hospitals, physician groups, and other healthcare providers to integrate its services into the broader healthcare ecosystem. These partnerships can enable the company to provide seamless care transitions, improve patient outcomes, and reduce hospital readmissions. The market for healthcare partnerships is estimated to be $15 billion annually.
What Opportunities Does ADUS Have?
- Expansion into new geographic markets.
- Strategic acquisitions of smaller providers.
- Development of specialized care programs.
- Increased focus on technology and innovation.
What Threats Does ADUS Face?
- Changes in government regulations and reimbursement policies.
- Increased competition from other providers.
- Economic downturn and reduced consumer spending.
- Cybersecurity threats and data breaches.
What Are ADUS's Competitive Advantages?
- Diversified service offerings across personal care, hospice, and home health segments.
- Established presence in multiple states, providing a broad geographic reach.
- Strong relationships with governmental agencies, managed care organizations, and commercial insurers.
- Reputation for providing high-quality care and customer service.
What Does ADUS Do?
Founded in 1979 and headquartered in Frisco, Texas, Addus HomeCare Corporation has evolved into a significant provider of home-based care services in the United States. The company operates through three primary segments: Personal Care, Hospice, and Home Health. The Personal Care segment offers non-medical assistance with activities of daily living, including bathing, grooming, meal preparation, and transportation. The Hospice segment provides palliative care, social work, spiritual counseling, and bereavement services for terminally ill patients and their families. The Home Health segment delivers skilled nursing, physical therapy, occupational therapy, and speech therapy to individuals recovering from illness or hospitalization. Addus serves a diverse range of payor clients, including governmental agencies, managed care organizations, commercial insurers, and private individuals. As of December 31, 2021, Addus operated through 206 offices in 22 states, reflecting its commitment to providing accessible and comprehensive care solutions to a growing population in need of in-home support.
What Products and Services Does ADUS Offer?
- Provides non-medical personal care services, including assistance with bathing, dressing, and meal preparation.
- Offers hospice care for terminally ill patients, including palliative nursing, social work, and spiritual counseling.
- Delivers skilled nursing and therapy services in the home, such as physical, occupational, and speech therapy.
- Assists with medication reminders and management.
- Provides transportation services for medical appointments and errands.
- Offers homemaking services, including light housekeeping and laundry.
- Provides bereavement counseling for families of hospice patients.
How Does ADUS Make Money?
- Generates revenue through fees for personal care, hospice, and home health services.
- Contracts with federal, state, and local governmental agencies to provide services to eligible individuals.
- Partners with managed care organizations and commercial insurers to provide services to their members.
- Receives payments directly from private individuals for services rendered.
What Industry Does ADUS Operate In?
Addus HomeCare operates within the expanding home healthcare industry, driven by an aging population and increasing preference for in-home care. The industry is characterized by fragmentation, with numerous regional and local providers. Key trends include the shift towards value-based care, increasing adoption of technology, and growing demand for specialized care services. Addus competes with other national and regional players, as well as local agencies. The company's diversified service offerings and geographic reach provide a competitive advantage in capturing market share. The U.S. home healthcare market is projected to reach $300 billion by 2028, reflecting a significant growth opportunity for companies like Addus.
Who Are ADUS's Key Customers?
- Elderly individuals who require assistance with activities of daily living.
- Chronically ill or disabled persons who need ongoing care and support.
- Individuals who are at risk of hospitalization or institutionalization.
- Terminally ill patients who require hospice care.
- Families who need support and assistance in caring for their loved ones.
Addus HomeCare Corporation (ADUS) Valuation Context
Valued at $1.98B, ADUS is classified as a small-cap stock. Relative to its peer group, ADUS's quantitative score of 92/100 is above the peer average of 61/100.
ADUS Revenue & Earnings Trend
In Q1 2026, ADUS generated $363.6M in top-line revenue, marking a sequential decrease of 2.5%. The company recorded net income of $25.1M, with diluted EPS of $1.36. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, ADUS averaged $1.35 in diluted EPS.
Company Profile
Addus HomeCare Corporation operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Frisco, US. The company is led by CEO R. Dirk Allison. ADUS has traded publicly since 2009.
ROE 9%Key Financial Metrics
Return on equity for Addus HomeCare Corporation stands at 9.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.3%, showing how much profit it generates from its asset base. ADUS trades at a trailing price-to-earnings ratio of 12.27, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.83 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
Addus HomeCare Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 5.62 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project Addus HomeCare Corporation revenue of about $1.52B for fiscal 2026, with EPS near $6.99. The estimate reflects 9 contributing analysts.
Net sellingInsider Activity
Over the past six months, Addus HomeCare Corporation insiders filed 30 SEC Form 4 transactions — 23 sales and 7 purchases. On net that is roughly 8K shares disposed (about $1.9M), a signal worth weighing alongside the fundamentals.
ADUS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Addus seems to be gaining traction in the social trading community, with more users discussing its potential for long-term growth in the home healthcare sector.
- Recent insider buying activity suggests that those within the company see value in the stock's current price, signaling confidence in future performance.
- The market perception of Addus is shifting positively as the demand for home healthcare services continues to rise due to an aging population.
- There's a growing belief that Addus is well-positioned to benefit from favorable demographic trends and increasing government support for home-based care.
Bear Case
- Some community members are expressing concerns that increased competition in the home healthcare market could impact Addus's market share and profitability.
- There are worries about potential regulatory changes that could negatively affect Addus's business model and reimbursement rates.
- A segment of the trading community believes that the company's growth prospects may already be priced into the stock, limiting further upside potential.
- Certain market observers are cautious about Addus's acquisition strategy, questioning whether the company can successfully integrate new businesses and achieve synergies.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · February 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $364M | $25M | $1.36 |
| Q4 2025 | $373M | $30M | $1.61 |
| Q3 2025 | $362M | $23M | $1.24 |
| Q2 2025 | $349M | $22M | $1.20 |
Based on FMP financials and quantitative analysis
ADUS Latest News
-
1 Value Stock Worth Your Attention and 2 Facing Challenges
Yahoo! Finance: ADUS News · Jun 1, 2026
-
Assessing Addus HomeCare (ADUS) Valuation After Recent Share Price Weakness
Yahoo! Finance: ADUS News · May 25, 2026
-
BrightSpring Leans Into Home Care as IRA Pricing Resets Hit
Yahoo! Finance: ADUS News · May 25, 2026
-
BTSG Q1 2026 Beat Shows Drivers of Margin Expansion
Yahoo! Finance: ADUS News · May 25, 2026
ADUS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ADUS.
Price Targets
Consensus target: $125.50
ADUS MoonshotScore
What does this score mean?
The MoonshotScore rates ADUS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
1 Value Stock Worth Your Attention and 2 Facing Challenges
Assessing Addus HomeCare (ADUS) Valuation After Recent Share Price Weakness
BrightSpring Leans Into Home Care as IRA Pricing Resets Hit
BTSG Q1 2026 Beat Shows Drivers of Margin Expansion
Latest Addus HomeCare Corporation Analysis
Leadership: R. Dirk Allison
CEO
R. Dirk Allison serves as the Chief Executive Officer of Addus HomeCare Corporation, bringing extensive experience in healthcare management and finance. His career includes leadership roles in various healthcare organizations, demonstrating a consistent track record of driving growth and operational efficiency. Allison's expertise spans strategic planning, financial management, and business development within the healthcare sector. His leadership is characterized by a focus on innovation and patient-centered care, positioning Addus for continued success in the evolving home healthcare landscape.
Track Record: Under R. Dirk Allison's leadership, Addus HomeCare Corporation has experienced significant growth through strategic acquisitions and organic expansion. He has overseen the successful integration of acquired companies, enhancing the company's service offerings and geographic reach. Allison has also focused on improving operational efficiency and enhancing the company's financial performance, contributing to increased shareholder value.
Addus HomeCare Corporation Healthcare Stock: Key Questions Answered
What does Addus HomeCare Corporation do?
Addus HomeCare Corporation provides a range of in-home care services, including personal care, hospice care, and home health services. The company focuses on serving elderly, chronically ill, and disabled individuals who require assistance with activities of daily living, palliative care, or skilled nursing and therapy. Addus operates through 206 offices in 22 states, contracting with governmental agencies, managed care organizations, commercial insurers, and private individuals to deliver its services. The company's mission is to provide high-quality, cost-effective care that enables individuals to remain in their homes and communities.
What do analysts say about ADUS stock?
Analyst consensus on Addus HomeCare Corporation (ADUS) reflects a generally positive outlook, driven by the company's strong market position and growth prospects in the expanding home healthcare industry. Key valuation metrics, such as the P/E ratio of 12.3, suggest that the stock is reasonably valued compared to its earnings. Growth considerations include the company's ability to expand into new geographic markets, acquire smaller providers, and capitalize on the increasing demand for in-home care services. However, analysts also note potential risks, such as regulatory changes and labor shortages, which could impact the company's performance. The overall sentiment is cautiously optimistic, with analysts anticipating continued growth and profitability for Addus.
What are the main risks for ADUS?
Addus HomeCare Corporation faces several key risks that could impact its financial performance and growth prospects. Regulatory changes and reimbursement pressures pose a significant threat, as changes in government regulations and reimbursement policies could negatively affect the company's revenue. Labor shortages in the healthcare industry could increase operating costs and limit service capacity. Economic downturns could reduce consumer spending on discretionary healthcare services. Increased competition from other national and regional home healthcare providers may erode market share. Cybersecurity threats and data breaches could compromise patient information and damage the company's reputation. Effective risk management strategies are crucial for Addus to mitigate these potential challenges.
What are the key factors to evaluate for ADUS?
Addus HomeCare Corporation (ADUS) holds an AI score of 92/100 (high). P/E: 12.3x vs the S&P 500's ~20-25x. Analysts target $125.50 (+18%). Not financial advice.
How frequently does ADUS data refresh on this page?
ADUS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ADUS's recent stock price performance?
Addus HomeCare Corporation (ADUS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings across personal care, hospice, and home health. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ADUS overvalued or undervalued right now?
Addus HomeCare Corporation (ADUS) trades at 12.3x earnings. Analysts target $125.50 (+18%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ADUS?
Before investing in Addus HomeCare Corporation (ADUS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on data available as of 2026-05-10.
- Future events and market conditions may impact the accuracy of this analysis.